42 related articles for article (PubMed ID: 25374130)
1. Association between serum TSH concentration and bone mineral density: an umbrella review.
Dziedzic M; Bonczar M; Ostrowski P; Stachera B; Plutecki D; Buziak-Bereza M; Hubalewska-Dydejczyk A; Walocha J; Koziej M
Hormones (Athens); 2024 Apr; ():. PubMed ID: 38581565
[TBL] [Abstract][Full Text] [Related]
2. Effect of Thyrotropin Suppression Therapy on Bone in Thyroid Cancer Patients.
Papaleontiou M; Hawley ST; Haymart MR
Oncologist; 2016 Feb; 21(2):165-71. PubMed ID: 26659220
[TBL] [Abstract][Full Text] [Related]
3. Body composition changes in patients with differentiated thyroid cancer after iodine-131 treatment and short-term levothyroxine replacement and suppression therapy.
Wang R; Qin S; Qiao T; Jiang W; Tong J; Lu G; Gao D; Zhang M; Lv Z; Li D; Chai L
Hormones (Athens); 2024 Jan; ():. PubMed ID: 38277093
[TBL] [Abstract][Full Text] [Related]
4. 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.
Lebbink CA; Links TP; Czarniecka A; Dias RP; Elisei R; Izatt L; Krude H; Lorenz K; Luster M; Newbold K; Piccardo A; Sobrinho-Simões M; Takano T; Paul van Trotsenburg AS; Verburg FA; van Santen HM
Eur Thyroid J; 2022 Dec; 11(6):. PubMed ID: 36228315
[TBL] [Abstract][Full Text] [Related]
5. Case report: fast reversal of severe osteoporosis after correction of excessive levothyroxine treatment and long-term follow-up.
Laine CM; Landin-Wilhelmsen K
Osteoporos Int; 2017 Jul; 28(7):2247-2250. PubMed ID: 28324131
[TBL] [Abstract][Full Text] [Related]
6. Benefits of thyrotropin suppression versus the risks of adverse effects in differentiated thyroid cancer.
Biondi B; Cooper DS
Thyroid; 2010 Feb; 20(2):135-46. PubMed ID: 20151821
[TBL] [Abstract][Full Text] [Related]
7. Follow-up of differentiated thyroid carcinoma.
Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
[TBL] [Abstract][Full Text] [Related]
8. Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
Reiners C; Biko J; Haenscheid H; Hebestreit H; Kirinjuk S; Baranowski O; Marlowe RJ; Demidchik E; Drozd V; Demidchik Y
J Clin Endocrinol Metab; 2013 Jul; 98(7):3039-48. PubMed ID: 23616148
[TBL] [Abstract][Full Text] [Related]
9. Bone mineral density in women receiving thyroxine suppressive therapy for differentiated thyroid carcinoma.
Chen CH; Chen JF; Yang BY; Liu RT; Tung SC; Chien WY; Lu YC; Kuo MC; Hsieh CJ; Wang PW
J Formos Med Assoc; 2004 Jun; 103(6):442-7. PubMed ID: 15278189
[TBL] [Abstract][Full Text] [Related]
10. Osteoporosis and thyrotropin-suppressive therapy: reduced effectiveness of alendronate.
Panico A; Lupoli GA; Fonderico F; Marciello F; Martinelli A; Assante R; Lupoli G
Thyroid; 2009 May; 19(5):437-42. PubMed ID: 19415993
[TBL] [Abstract][Full Text] [Related]
11. Changes of bone mineral density in pre-menopausal women with differentiated thyroid cancer receiving L-thyroxine suppressive therapy.
Mazokopakis EE; Starakis IK; Papadomanolaki MG; Batistakis AG; Papadakis JA
Curr Med Res Opin; 2006 Jul; 22(7):1369-73. PubMed ID: 16834835
[TBL] [Abstract][Full Text] [Related]
12. Effects of TSH suppressive therapy on bone mineral density (BMD) and bone turnover markers (BTMs) in patients with differentiated thyroid cancer in Northeast China: a prospective controlled cohort study.
Wang S; Wang Y; Zhu L; He L; Lv M; Zhang H; Wang H; Zhang F; Lai Y; Li Y; Shan Z; Teng W
Endocrine; 2023 Jan; 79(1):113-124. PubMed ID: 36089636
[TBL] [Abstract][Full Text] [Related]
13. Bone mineral density in treated at a young age for differentiated thyroid cancer after Chernobyl female patients on TSH-suppressive therapy receiving or not Calcium-D3 supplementation.
Leonova TA; Drozd VM; Saenko VA; Mine M; Biko J; Rogounovitch TI; Takamura N; Reiners C; Yamashita S
Endocr J; 2015; 62(2):173-82. PubMed ID: 25374130
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
